Related Articles
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
Extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: A case report of successful diagnosis and treatment
Aberrantly expressed transcription factors C/EBP and SOX4 have positive effects in the development of chronic myeloid leukemia
BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML
Preliminary data on microRNA expression profiles in a group of South African patients diagnosed with chronic myeloid leukaemia